Search results (125)
« Back to NewsStudy reveals barriers to Hepatitis C care in Vietnam’s public healthcare
24 November 2023
A recent study led by OUCRU researchers highlighted the factors associated with the number of visits to one tertiary public hospital (Hospital for Tropical Diseases in Ho Chi Minh City) that serves as the referral clinic for two-thirds of Vietnam for Hepatitis C virus treatment.
Combatting Antimicrobial Resistance: OUCRU's Fight Against the Silent Pandemic
23 November 2023
OUCRU are tackling the global health threat of Antimicrobial Resistance – a silent pandemic claiming millions of lives yearly. Learn about our collaborative research, our interventions in local hospitals, and our ongoing efforts to combat AMR.
Youth Against Antimicrobial Resistance: Empowering the Future
23 November 2023
Antimicrobial resistance (AMR) is a global health crisis that jeopardizes our ability to effectively treat infections caused by bacteria, viruses, and parasites. To address this urgent issue, OUCRU has been implementing projects involving the youth and empowering young individuals to take action and make a difference.
Public Engagement Activities in Nepal to celebrate World AMR Awareness Week
22 November 2023
OUCRU OUCRU-Nepal Public Engagement
As part of the global efforts to raise awareness about Antimicrobial Resistance (AMR) during World AMR Awareness Week, OUCRU Nepal has been actively engaging in public outreach activities since 2016. These initiatives aim to educate and empower individuals to take action in preventing the spread of AMR and promote responsible antibiotic use in the country.
World AMR Awareness and Public Engagement at OUCRU
21 November 2023
At OUCRU, we are committed to raising awareness about antimicrobial resistance in the communities we work with. To fulfil our commitment, OUCRU’s Public and Community Engagement team has organised several activities and projects across our sites. The aim has been to educate and empower individuals to take action in preventing the spread of AMR by promoting responsible antibiotic use.
Antimicrobial resistance is a silent killer that leads to 5 million deaths a year. Solutions must include the poor
19 November 2023
AMR has been linked to close to 5 million deaths annually. We need urgent global action to counter antimicrobial resistance, but current efforts focus on solutions developed in high-income settings. If we want people to become less dependent on antibiotics, we must address the factors that create dependency on antibiotics in the first place. The solution we are working towards is fair and inclusive; it respects people and their traditions while also benefiting human health, animal welfare and the natural environment.
OUCRU joins UK-Vietnam partnership to enhance Ho Chi Minh City’s Health Innovation
1 November 2023
OUCRU will be a part of a new initiative aimed at developing a strategic roadmap for Ho Chi Minh City to become a regional Health Innovation Hub. The project, supported by a £75,000 grant from the UK Government, is a strategic move to transform Ho Chi Minh City into ASEAN's leading health innovation centre.
OUCRU Bolsters Ho Chi Minh City’s Responses to Emerging Infectious Diseases
24 October 2023
In collaboration with Ho Chi Minh City's healthcare sector, OUCRU has successfully identified the primary agent causing the outbreak of pink eye disease. Testings revealed an unexpected finding: enterovirus was the primary agent, contrary to previous reports from Vietnam wherein adenovirus was the culprit.
Investigating dexamethasone for tuberculous meningitis in HIV-Positive adults
13 October 2023
The ACT HIV trial conducted by NDM’s Oxford University Clinical Research Unit (OUCRU), investigated the effectiveness of dexamethasone in reducing death, disability, and other complications in HIV-positive adults with tuberculous meningitis.
Recap on the webinar Mental Healthcare for Carers and Celebrating World Mental Health Day
10 October 2023
On October 7th, we had the privilege of hosting a live webinar together with the Vietnamese Psychotherapy Association (VnPA) and Medisetter, titled “Mental Healthcare for Carers: We Support the Supporters!” in honour of World Mental Health Day 10th October 2023.
Mental Healthcare for Carers: We Support the Supporters!
9 October 2023
October 10th is World Mental Health Day. This year, the global theme, “Our Minds, Our Rights,” emphasises the universal right to access mental healthcare services as part of basic healthcare, which is considered one of our fundamental human rights.
New evidence supports higher dose antimalarial to combat relapsing malaria
26 September 2023
MORU NDM-CGHR OUCRU OUCRU-Indonesia SMRU
Analysis of data from more than 6,800 patients located across 16 countries has supported the need to increase the dose of the antimalarial drug, primaquine, in Plasmodium vivax malaria endemic countries.
Three CTMGH researchers awarded Professorships
19 September 2023
Awards & Appointments KWTRP MORU OUCRU
We are delighted to announce that three of our researchers have been awarded the Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
Identifying factors for maternal and foetal mortality from malaria
31 August 2023
A study coordinated by NDM researchers published in BMC Medicine explores the factors predicting higher mortality in pregnant women with severe malaria and describes how severe falciparum malaria in pregnancy affects foetal health and mortality.
Large-scale Study Examines Impact of COVID-19 Pandemic on Tuberculosis Control in Indonesia
22 August 2023
A new study published in The Lancet Global Health highlights the devastating impact of the COVID-19 pandemic on tuberculosis (TB) control in Indonesia, the nation with the second highest TB burden globally and the second highest burden of COVID-19 in the Asian region.
Researchers call for standardisation of antibiotics to help fight resistance
16 August 2023
The ABACUS II Consortium, which includes the Medicine Quality Research Group, published a new viewpoint calling for the standardisation of antibiotics appearance and better information around usage. Changes to the appearance of antibiotic medicines could help avoid confusion and reduce misuse. These measures could help reduce antibiotic resistance, an urgent and global problem that is growing every year.
New collaboration to improve clinical research in low-resource settings
11 August 2023
Four major clinical trial networks, including Oxford University Clinical Research Unit, The Global Health Network, hosted by NDM’s Centre for Tropical Medicine and Global Health, based in low-resource settings are embarking on an exciting partnership with the Good Clinical Trials Collaborative (GCTC) to enhance clinical research in low-resource settings.
World Hepatitis Day: OUCRU research seeks to lower cost of treatment and improve access to care for patients with Hepatitis C
28 July 2023
According to the World Health Organisation, 10-15% of Vietnam’s population is estimated to have viral hepatitis, including 1,07 million people who have Hepatitis C. Over 90% of those who have Hepatitis C are not aware of their positive status. OUCRU, the Hospital for Tropical Diseases (Ho Chi Minh City), and Vietnam’s National Hospital for Tropical Diseases (Hanoi) have been collaborating on Hepatitis C clinical trials since 2018. Our research is centred around predictive factors for selecting persons who could be successfully treated with shorter durations of antiviral therapy for Hepatitis C.
Opportunities and Challenges in Applying Artificial Intelligence and Digital Health Technologies in Viet Nam
14 July 2023
Digital health and artificial intelligence have the potential to transform healthcare, making health care management more efficient and accessible. However, a new paper by Ho Quang Chanh et al, detailed why engagement with policymakers, local patients and healthcare workers, and integrating with local systems and practice are crucial to ensure that digital health technologies can thrive in low- and middle-income settings.
Dr Marlous Grijsen Awarded the International Award for Social Responsibility in Dermatology
5 July 2023
The OUCRU Indonesia project, “Improving access to skincare through teledermatology in Eastern Indonesia”, is one of five laureates selected this year from 193 applications in 66 countries by an independent scientific committee of five dermatologists and ILDS board members.
Four CTMGH researchers awarded Associate Professorships
23 May 2023
Awards & Appointments KWTRP MORU OUCRU
We are delighted to announce that four of our researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
OUCRU Project Raises Vaccination Uptake in Ethnic Minority Communities in Dak Lak, Viet Nam
23 May 2023
OUCRU, in collaboration with Dak Lak’s Department of Health and Centre for Disease Control (CDC), developed a training programme to enhance the capacity of commune vaccine staff, with a particular focus on supporting their communication about the vaccines and vaccination process.
Global team of humanities and social science researchers to explore Just Transitions for antimicrobial resistance
9 May 2023
'Just Transitions to mitigate antimicrobial resistance' is a multidisciplinary social science and humanities programme funded by the British Academy. Led by Dr Sonia Lewycka and Professor Phaik Yeong Cheah, its team of 20 researchers will convene global and regional dialogues, engaging with key stakeholders to co-create equitable and sustainable solutions to manage antimicrobial resistance.
Public Engagement in Vaccine Uptake projects at OUCRU
5 May 2023
OUCRU OUCRU-Nepal Public Engagement
Vaccines are the most effective and affordable way to prevent diseases. The pandemic led to a lag in immunisation for essential vaccines – 25 million children worldwide missed out on vaccination in 2021, according to WHO. At OUCRU, in addition to research and collaborations on various vaccine projects, we are committed to public and community engagement and education around vaccines. Look at some engagement projects that help raise awareness about vaccination and build the capacity for frontline healthcare workers, especially in rural areas.
How Socio-cultural Factors Impact the Consent Process in Clinical Trials
6 April 2023
OUCRU study explored why participants made decisions to participate in clinical trials and outlined ways to improve participants’ experience during the informed consent process.
ACORN investigators meet to kick off 2nd year of data collection
5 April 2023
Funded by Wellcome, ACORN (A Clinically-Oriented antimicrobial Resistance Network) is an AMR surveillance project that collects clinical and microbiology data on community- and hospital-acquired infections. ACORN will assess the impacts of AMR on the duration of hospitalisation and mortality in collaboration with the WHO Global AMR Surveillance System (GLASS) team.
Improving access to care for people in Vietnam impacted by Hepatitis C: dissemination workshop to share findings of OUCRU’s community-based participatory research
22 March 2023
OUCRU and HCMC Hospital for Tropical Diseases host a one-day research dissemination workshop for policy, healthcare, community, and research stakeholders. The workshop is the culmination of an OUCRU project: “Community-based participatory research to promote engagement with underserved communities at risk of Hepatitis C virus in Ho Chi Minh City, Vietnam”.
The journey of dreams, improving engagement with underserved populations at risk for Hepatitis C in Vietnam.
22 March 2023
OUCRU Public and Community Engagement team produced a video based on their project “Community-based participatory research to promote engagement with underserved communities at risk of Hepatitis C virus in Ho Chi Minh City, Vietnam”. This video was made by community members of the community-based participatory research to the project. The video is in Vietnamese with English subtitles
Watch our webinar - Radical cure of vivax malaria: can we do better?
1 March 2023
The three presentations and expert discussion by Dr Rob Commons, Dr Alison Roth and Dr James Watson, chaired by Professor Sir Nicholas White (Mahidol Oxford Research Unit) and Dr Chau Nguyen Hoang (Oxford University Clinical Research Unit), are now available.
Multidisciplinary dengue forecasting project launches in Vietnam
7 February 2023
DART (Dengue Advanced Readiness Tools), is a new project supported by Wellcome to use climate data to better predict and prepare for infectious diseases outbreaks.
OUCRU’s Photographer In Residence Featured In The Lancet’s Highlights 2022
23 December 2022
Photographs have the power to inform and engage viewers. Earlier this year, The Lancet invited submissions for Highlights, the publication’s annual photography competition. Highlights 2022 featured 14 winning photographs telling stories from a wide variety of health-related topics that captured the world’s attention in 2022. One of the powerful images selected was from Pearl Gan, OUCRU’s Photographer in Residence.
Researchers call for antimicrobial resistance surveillance to be improved
20 December 2022
COMRU LOMWRU MORU NDM-CGHR OUCRU
The number of studies reporting antimicrobial resistance (AMR) data has increased in Africa, South and South East Asia according to new research in the International Journal of Infectious Diseases.
Are we getting tafenoquine dosing right?
6 December 2022
Researchers analysing clinical trial data for the new antimalarial drug tafenoquine find that higher doses are needed to cure reliably vivax malaria infection.
Letter from the hills: The invisible burden of leprosy in Sumba
18 November 2022
OUCRU Indonesia launches a new exhibition by photographer Yoppy Pieter based in Jakarta, Indonesia. This exhibition documents, through a series of intimate and beautiful images, the invisible burden of leprosy and other skin diseases in Sumba, an island in Nusa Tenggara Timor province, Indonesia.
Combating Antimicrobial Resistance
18 November 2022
November 18 – 24 is World Antimicrobial Awareness Week. Antimicrobial resistance has been a key focus in OUCRU’s research for many years. Our objective is to understand and improve antimicrobial use and antimicrobial resistance in agriculture, the community, and hospitals. Our approach is interdisciplinary – led by a number of OUCRU’s research groups and public engagement teams.
OUCRU Engagement around mental health
25 October 2022
OUCRU’s Public and Community Engagement team develops training and resources on the topic of stress management and communication skills. Run by the Public and Community Engagement team, the Youth Ambassadors programme also links young people to medical research that impacts their lives and connects researchers to the health issues that young people care about.
Abhilasha Karkey, new OUCRU Nepal Director
18 October 2022
Awards & Appointments OUCRU OUCRU-Nepal
OUCRU Nepal is pleased to announce that as of 01 October 2022, Dr Abhilasha Karkey will assume the role of Director.
OUCRU presents a new virtual exhibition: Digital Diaries, Voices from the Pandemic, COVID-19 experiences in Asia
13 September 2022
OUCRU OUCRU-Indonesia OUCRU-Nepal Public Engagement
This online exhibition showcases short films and photographs created by health-care workers and community members and documents the socio-cultural impact of the COVID-19 pandemic in Indonesia, Nepal and Vietnam.
World Hepatitis Day: OUCRU research seeks to lower cost of treatment and improve access to care for patients with hepatitis C
28 July 2022
Today is World Hepatitis Day. OUCRU and hospitals in Ho Chi Minh City and Hanoi have been collaborating on hepatitis C clinical trials since 2018. Our research is centred around predictive factors for selecting persons who could be successfully treated with shorter durations of antiviral therapy. OUCRU’s social science and public engagement teams are currently working with underrepresented groups to create community-led strategies to link care and treatment for populations at risk for viral hepatitis. Our aim is to have a more significant impact on the treatment strategy and access to care for patients with hepatitis C in Vietnam and worldwide in the future.
Prof Guy Thwaites co-authored WHO’s report on antibacterial agents in preclinical & clinical development
5 July 2022
OUCRU’s Director, Professor Guy Thwaites, has recently contributed to an analysis of antibacterial agents in preclinical and clinical development by the World Health Organisation (WHO), as part of the WHO advisory group on research and development of antibacterial treatments.
Dengue Research Article Awarded The 2021 – 2022 Alexandre Yersin Prize for Outstanding Publications
28 June 2022
OUCRU research article titled ‘Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes’ was recently awarded the 2021-2022 Alexandre Yersin Prize for Outstanding Publications.
OUCRU SPEAR Digital Diaries
21 June 2022
OUCRU OUCRU-Indonesia OUCRU-Nepal Public Engagement
Healthcare workers and community members in Indonesia, Nepal and Vietnam have been documenting their personal experiences of Covid-19. They have each made their own ‘digital diary’, using a range of creative tools and with technical support from the project team. These diaries form part of the SPEAR project: exploring the experiences and impacts of COVID-19 for healthcare workers and vulnerable communities.
Clinical trials for a malaria vaccine start in Mali and Indonesia
21 June 2022
Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.
Congratulations to our new Associate Professors
8 June 2022
Awards & Appointments KWTRP OUCRU
Our heartfelt congratulations to Melissa Kapulu, Francis Ndungu and Emelda Okiro from KWTRP, and to Hoa Thi Ngo and Sophie Yacoub from OUCRU who have been awarded Associate Professorships
First-of-its-kind study found equine antitoxin is safe and effective for the treatment of tetanus in adults
24 May 2022
A first-of-its kind randomised controlled trial compared two different antitoxin treatments for tetanus. A comparison of human and equine intramuscular antitoxin in adults found that intramuscular equine antitoxin is safe and effective for treating tetanus in adults. Addition of additional intrathecal (spinal) antitoxin does not add any benefit compared to treatment with intramuscular antitoxin alone.
Picturing Health: The Burden of Leprosy in Eastern Indonesia
26 April 2022
OUCRU OUCRU-Indonesia Public Engagement
The Eijkman Oxford Clinical Research Unit in Indonesia and Sumba Foundation collaborated with photographer Yoppy Pieter to express the human face of leprosy in Sumba, a remote island in eastern Indonesia. The project aimed to visualize the story of leprosy and raise awareness of this debilitating and heavily stigmatised disease
Research Culture at OUCRU
6 April 2022
What do we mean by 'Research Culture' and how has fostering a multinational, collaborative culture helped us deliver world-class research? Let's explore the research culture at OUCRU.
Policy and Public Engagement at OUCRU
29 March 2022
OUCRU OUCRU-Indonesia Public Engagement Video
Why does OUCRU place an important focus on engaging with its important partners, policy makers, the press, the community, and young people? Explore our work in policy & public engagement.
World TB Day 2022: Invest to End TB. Save Lives
24 March 2022
Each year on 24 March, World TB Day is commemorated to raise awareness of this devastating and deadly disease. The theme for this year’s World TB Day is “Invest to End TB. Save Lives”, conveying the urgent need to invest resources to ramp up the fight against TB and achieve the commitments to end TB made by global leaders.
TACT-CV study shows artemether–lumefantrine plus amodiaquine an effective treatment for multidrug-resistant malaria in GMS
22 March 2022
A triple artemisinin-based combination therapy (TACT) of artemether-lumefantrine plus amodiaquine (AL+AQ) for uncomplicated falciparum malaria in areas with a high prevalence of artemisinin resistance is a well-tolerated, effective treatment for multidrug-resistant parasites, say a team of MORU-led researchers.